Former U.S. Rep. Mia Love of Utah, a daughter of Haitian immigrants who became the first Black Republican woman elected to ...
U.S. Transportation Secretary Sean Duffy offered some blunt advise on how New York’s governor should address the subway ...
A coach who was fired within hours of pulling a player’s ponytail after a loss in a New York girls basketball state ...
U.S. Education Secretary Linda McMahon says Columbia University is “on the right track” to recover federal funding frozen by ...
Following his reinstatement, Han told reporters he would focus global trade, an apparent reference to the Trump ...
The Democratic congresswoman from New York has been on the road with Vermont Sen. Bernie Sanders for his “Fighting Oligarchy” ...
The runup to release was plagued by controversies over the film’s handling of the dwarfs, who are CGI, and backlashes over ...
China’s artificial intelligence space is moving towards free-use, open-sourced models in a trend that experts say will ...
Aaron Hernandez’s fiancée Shayanna Jenkins honored the late NFL star almost eight years after his death in prison with an ...
The Ukrainian delegation is expected to meet with U.S. officials in Saudi Arabia a day before the indirect talks, Ukraine’s ...
On March 20, the food delivery platform announced a collab with Klarna, an AI-powered online payments company, to offer a ...
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial results have left investors feeling unsatisfied.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results